Turnstone Biologics Corp. (TSBX) Income Statement

Last quarter (Q2 2024), Turnstone Biologics Corp.'s total revenue was $―, a decrease of ― from previous quarter. In Q2, Turnstone Biologics Corp.'s net income was $-21.30M. See Turnstone Biologics Corp.’s key income statements, including revenue, expenses, profit, and income.